日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

CD19 CAR-T 细胞治疗难治性自身免疫性疾病:CASTLE 篮子试验(1/2 期)

Müller, Fabian; Hagen, Melanie; Wirsching, Andreas; Kharboutli, Soraya; Aigner, Michael; Völkl, Simon; Kretschmann, Sascha; Tascilar, Koray; Taubmann, Jule; Bucci, Laura; Raimondo, Maria Gabriella; Bergmann, Christina; Rothe, Tobias; Corte, Giulia; Tur, Carlo; Muñoz, Luis; Böltz, Sebastian; Schuster, Louis; Hartmann, Fabian; Garantziotis, Panagiotis; Spörl, Silvia; Vasova, Ingrid; Gerbitz, Armin; Spriewald, Bernd; Kiener, Hans; Giannarelli, Diana; Locatelli, Franco; D'Agostino, Maria-Antonietta; Hanssens, Linda; Miltenyi, Stefan; Bozec, Aline; Grieshaber-Bouyer, Ricardo; Mackensen, Andreas; Schett, Georg

Universal high-sensitivity CAR T-cell monitoring by targeting linker sequences.

通过靶向连接序列实现通用高灵敏度 CAR T 细胞监测。

Schwingen Nora Rebecca, Meretuk Lina, Aigner Michael, Kretschmann Sascha, Scholz Julia Katharina, Gsottberger Franziska, Harrer Dennis Christoph, Dingfelder Janin, Lutzny-Geier Gloria, Kharboutli Soraya, Mackensen Andreas, Müller Fabian, Völkl Simon

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

伊达卡巴基因维克鲁塞尔或西他卡巴基因自体白细胞介素治疗复发或难治性多发性骨髓瘤:一项国际多中心研究

Merz, Maximilian; Albici, Anca-Maria; von Tresckow, Bastian; Rathje, Kristin; Fenk, Roland; Holderried, Tobias; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Vucinic, Vladan; Kharboutli, Soraya; Bärmann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Stölzel, Friedrich; Schub, Nathalie; Schmitz, Friederike; Fandrei, David; Born, Patrick; Khandanpour, Cyrus; Hanoun, Christine; Hörster, Keven; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; de Larrea, Carlos Fernández; Pabst, Thomas; Gagelmann, Nico

[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]

[CD19-CAR T细胞治疗系统性红斑狼疮的长期疗效和安全性随访]

Taubmann, Jule; Böltz, Sebastian; Hagen, Melanie; Wirsching, Andreas; Müller, Fabian; Völkl, Simon; Kharboutli, Soraya; Spörl, Silvia; Garantziotis, Panagiotis; Aigner, Michael; Grieshaber-Bouyer, Ricardo; Mackensen, Andreas; Schett, Georg

Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy

靶向BCMA或GPRC5D的双特异性抗体在CAR-T细胞疗法后复发的多发性骨髓瘤中疗效显著。

Merz, Maximilian; Dima, Danai; Hashmi, Hamza; Ahmed, Nausheen; Stölzel, Friedrich; Holderried, Tobias A W; Fenk, Roland; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Rathje, Kristin; Davis, James A; Fandrei, David; Vucinic, Vladan; Kharboutli, Soraya; Baermann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Albici, Anca-Maria; Schub, Nathalie; Schmitz, Friederike; Shune, Leyla; Khouri, Jack; Anwer, Faiz; Raza, Shahzad; McGuirk, Joseph; Mahmoudjafari, Zahra; Green, Kimberly; Khandanpour, Cyrus; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; von Tresckow, Bastian; de Larrea, Carlos Fernández; Pabst, Thomas; Abdallah, Al-Ola; Gagelmann, Nico

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

欧盟患者接受 CD19 CAR-T 治疗复发/难治性大 B 细胞淋巴瘤的疗效劣于美国患者:与肿瘤负荷、全身炎症、桥接治疗利用率和 CAR-T 产品使用情况的差异相关

Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; von Bergwelt, Michael; Barba, Pere; Subklewe, Marion; Jain, Michael D

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL

在复发/难治性B细胞非霍奇金淋巴瘤(B-NHL)患者接受CD19 CAR-T治疗后,通过常规和探索性血清蛋白质组学以及HT10评分识别CRS背景下的早期感染

Rejeski, Kai; Blumenberg, Viktoria; Iacoboni, Gloria; Lopez-Corral, Lucia; Kharboutli, Soraya; Hernani, Rafael; Petrera, Agnese; Müller, Niklas; Hildebrand, Friederike; Frölich, Lisa; Karschnia, Philipp; Schmidt, Christian; Cordas Dos Santos, David M; Piñana, José Luis; Müller, Fabian; Martin, Ana Africa; Dreyling, Martin; von Bergwelt-Baildon, Michael; Barba, Pere; Subklewe, Marion; Bücklein, Veit L

Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen

利用基于适体筛选鉴定的粪便蛋白预测溃疡性结肠炎的疾病进程

Sanam Soomro # ,Suresh Venkateswaran # ,Kamala Vanarsa ,Marwa Kharboutli ,Malavika Nidhi ,Ramya Susarla ,Ting Zhang ,Prashanth Sasidharan ,Kyung Hyun Lee ,Joel Rosh ,James Markowitz ,Claudia Pedroza ,Lee A Denson ,Jeffrey Hyams ,Subra Kugathasan ,Chandra Mohan

Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report

抗CD19 CAR-T细胞治疗后获得性血小板减少症的血小板生成素受体激动剂治疗:病例报告

Baur, Rebecca; Jitschin, Regina; Kharboutli, Soraya; Stoll, Andrej; Völkl, Simon; Büttner-Herold, Maike; Schmidt, Daniela; Rösler, Wolf; Mackensen, Andreas; Mougiakakos, Dimitrios

Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis

胰岛素样生长因子结合蛋白-2作为狼疮性肾炎疾病活动性和肾脏病理变化的新型生物标志物

H Ding, M Kharboutli, R Saxena, T Wu